13F-HR filed by Ariose Capital Management Ltd
Ariose Capital Management Ltd filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-04-29, with 5 holding rows worth $25,587,000.
- Accession
- 0001085146-22-001614
- Filer
- CIK 1665925
- Filed
- 2022-04-29
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 5 entries on the cover page, a total value of $25,587,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $25,587,000 with VALUE read as thousands by filing date, 13F file number 028-17188. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 83,770 | $9,114,000 | thousands by filing date | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 127,600 | $7,384,000 | thousands by filing date | |
| NETEASE COM INC SPONSORED ADS | 64110W102 | ADR | 41,400 | $3,713,000 | thousands by filing date | |
| Netflix, Inc | 64110L106 | COM | 8,000 | $2,997,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 37,900 | $2,379,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-22-001614 | this filing | 2022-04-29 | acceptance time not in the bulk data set |